A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
- PMID: 32737595
- PMCID: PMC7395005
- DOI: 10.1007/s11538-020-00780-5
A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer
Abstract
Oncolytic virotherapy is known as a new treatment to employ less virulent viruses to specifically target and damage cancer cells. This work presents a cellular automata model of oncolytic virotherapy with an application to pancreatic cancer. The fundamental biomedical processes (like cell proliferation, mutation, apoptosis) are modeled by the use of probabilistic principles. The migration of injected viruses (as therapy) is modeled by diffusion through the tissue. The resulting diffusion-reaction equation with smoothed point viral sources is discretized by the finite difference method and integrated by the IMEX approach. Furthermore, Monte Carlo simulations are done to quantitatively evaluate the correlations between various input parameters and numerical results. As we expected, our model is able to simulate the pancreatic cancer growth at early stages, which is calibrated with experimental results. In addition, the model can be used to predict and evaluate the therapeutic effect of oncolytic virotherapy.
Keywords: Cancer treatment; Cellular automata; Computational modeling; Monte Carlo simulations; Virotherapy.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Aghi M, Martuza RL. Oncolytic viral therapies-the clinical experience. Oncogene. 2005;24(52):7802. - PubMed
-
- Bajaj B, Lei P, Andreadis ST. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol Progr. 2001;17(4):587–596. - PubMed
-
- Bommareddy PK, Shettigar M, Kaufman HL. Integrating oncolytic viruses in combination cancer immunotherapy. Nat Rev Immunol. 2018;18(8):498. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394–424. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
